Recent improvements in high-throughput proteomic approaches are likely to constitute an
essential advance in biomarker discovery, holding promise for improved personalized care …

Importance Identifying psychosis subgroups could improve clinical and research precision.
Research has focused on symptom subgroups, but there is a need to consider a broader …

In current diagnostic systems, schizophrenia and bipolar disorder are still conceptualized as
distinct categorical entities. Recently, both clinical and genomic evidence have challenged …

Importance No clinically applicable diagnostic test exists for severe mental disorders. Lipids
harbor potential as disease markers. Objective To define a reproducible profile of lipid …

Background Studying phenotypic and genetic characteristics of age at onset (AAO) and
polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and …

As early detection of symptoms in the subclinical to clinical psychosis spectrum may improve
health outcomes, knowing the probabilistic susceptibility of developing a disorder could …

Objectives Bipolar disorder (BD) with early disease onset is associated with an unfavorable
clinical outcome and constitutes a clinically and biologically homogenous subgroup within …

Background Religious delusions are a common symptom in patients experiencing psychosis,
with varying prevalence rates of religious delusions across cultures and societies. To …

Cognitive deficits are a core feature of psychiatric disorders like schizophrenia and bipolar
disorder. Evidence supports a genome-wide polygenic score (GPS) for educational …

Executive functions are metacognitive capabilities that control and coordinate mental
processes. In the transdiagnostic PsyCourse Study, comprising patients of the affective-to-…